LAB vs USB
Standard Biotools Inc (LAB) versus U.S. Bancorp (USB) — a side-by-side from cached financials, not a winner call.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
U.S. Bancorp (USB) is a banks - regional company listed on US.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
Latest reported USB revenue for 2025-12-31 was $28.66B. Net income was $7.57B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. USB currently screens at market cap $74.68B and trailing P/E 11.9.
LAB currently screens at market cap $317.1M. USB currently screens at market cap $74.68B and trailing P/E 11.9.
Not investment advice. Open the LAB and USB stock pages for the full models.
Not investment advice.